Q2 2025 Holdings
Filed 2025-08-11 | 73 holdings | $309.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $65.4M | 4,039,553 | 21.1% |
| Blue OWL Capital Corporation(OBDC) | COM | 69121K104 | $29.3M | 2,045,070 | 9.5% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $18.0M | 2,385,972 | 5.8% |
| Evercommerce Inc(EVCM) | COM | 29977X105 | $17.2M | 1,641,929 | 5.6% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $15.9M | 997,107 | 5.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $14.2M | 4,928,040 | 4.6% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $13.6M | 3,728,106 | 4.4% |
| Conduent Inc(CNDT) | COM | 206787103 | $11.8M | 4,456,848 | 3.8% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $10.1M | 1,328,351 | 3.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $9.3M | 255,238 | 3.0% |
| Holley Inc(HLLY) | COM | 43538H103 | $8.2M | 4,112,361 | 2.7% |
| Civeo Corp CDA(CVEO) | COM NEW | 17878Y207 | $7.3M | 317,411 | 2.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $6.7M | 2,591,525 | 2.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $6.5M | 122,260 | 2.1% |
| Ikena Oncology Inc | COM | 45175G108 | $5.5M | 4,091,118 | 1.8% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $5.3M | 562,594 | 1.7% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $5.1M | 80,167 | 1.6% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $4.9M | 7,407,906 | 1.6% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $4.8M | 3,443,659 | 1.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.5M | 335,944 | 1.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $4.3M | 330,600 | 1.4% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $4.2M | 814,416 | 1.3% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $3.6M | 1,329,912 | 1.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $3.4M | 2,969,199 | 1.1% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $3.0M | 920,000 | 1.0% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $2.8M | 125,259 | 0.9% |
| Starwood Ppty TR Inc(STWD) | COM | 85571B105 | $2.6M | 131,461 | 0.9% |
| Dell Technologies Inc(DELL) | CL C | 24703L202 | $2.6M | 20,848 | 0.8% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $2.3M | 1,300,000 | 0.8% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $2.0M | 733,568 | 0.6% |
| Fold Hldgs Inc(FLD) | COM CL A | 29103K100 | $1.9M | 856,632 | 0.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.7M | 18,347 | 0.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.7M | 1,125,000 | 0.6% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $1.6M | 125,000 | 0.5% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $1.5M | 35,000 | 0.5% |
| Servicetitan Inc(TTAN) | SHS CL A | 81764X103 | $1.2M | 11,350 | 0.4% |
| Enterprise Prods Partners L(EPD) | COM | 293792107 | $970.3K | 31,290 | 0.3% |
| Marker Therapeutics Inc(MRKR) | COM NEW | 57055L206 | $848.0K | 554,250 | 0.3% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $643.8K | 229,914 | 0.2% |
| Rezolve AI PLC(RZLV) | ORD SHS | G75398100 | $558.6K | 181,667 | 0.2% |
| Alpha Modus Hldgs Inc(AMOD) | CL A | 020952107 | $418.1K | 394,078 | 0.1% |
| Rezolve AI PLC | *W EXP 08/15/202 | G75398118 | $381.3K | 476,685 | 0.1% |
| Southland Hldgs Inc(SLND/WS) | *W EXP 02/14/202 | 84445C118 | $294.1K | 860,302 | 0.1% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $288.6K | 1,718 | 0.1% |
| Niocorp Devs LTD(NIOBW) | *W EXP 03/17/202 | 654484153 | $277.3K | 546,442 | 0.1% |
| Alpha Modus Hldgs Inc(AMODW) | *W EXP 12/13/202 | 020952115 | $201.5K | 1,854,665 | 0.1% |
| SHF Holdings Inc(SHFS) | CL A NEW | 824430300 | $164.7K | 75,897 | 0.1% |
| Blacksky Technology Inc(BKSY/WS) | *W EXP 09/09/202 | 09263B116 | $103.5K | 350,000 | 0.0% |
| Syntec Optics Hldgs Inc(OPTXW) | *W EXP 99/99/999 | 87169M113 | $69.8K | 803,132 | 0.0% |
| Dave Inc | *W EXP 01/05/202 | 23834J110 | $52.0K | 28,750 | 0.0% |